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A B S T R A C T
Objective: This study was designed to identify factors associated with the femoral neck bone mineral
density (FNBMD) of the very elderly (aged 80 or more) Chinese males.
Methods: A total of 1177 very elderly Chinese males were recruited into the study, and subjected to
FNBMD, biochemical parameters, bone turnover markers, and serum sex steroids assays. Univariate and
multivariate regression analyses were performed to identify factors independently related to FNBMD.
Results: It was demonstrated that age (b = 0.003, P = 0.035), concomitant chronic obstructive pulmonary
disease (COPD, b = 0.027, P = 0.009), serum b-C-telopeptide of type 1 collagen (b-CTX, b = 0.097,
P < 0.001), and parathyroid hormone (PTH, b = 0.001, P = 0.004) were negatively correlated with the
FNBMD, while body mass index (BMI, b = 0.009, P < 0.001), and serum estradiol (b = 0.001, P = 0.038) were
positively related to FNBMD in very elderly Chinese males.
Conclusion: An integrated intervention should be implemented to increase the BMD of the very elderly
males, with special attention to preventing and curing COPD, reducing serum b-CTX and PTH levels, as
well as keeping a proper BMI and serum estradiol level.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The prevalence of osteoporosis has been increased exponen-
tially due to the aging of the population, which makes it a major
public health problem worldwide. Osteoporosis is characterized by
low bone mass and deterioration of bone microarchitecture,
leading to increased bone fragility and a consequent high risk of
fracture (Park et al., 2011). As a major contributor to the global
population, China becomes the most important source of
osteoporosis-related fractures. A recent study has demonstrated
that low bone mineral density (BMD) as well as osteoporosis of the
femoral neck are independent risk factors for stroke and death
(Nordström, Eriksson, Stegmayr, Gustafson, & Nordström, 2010).
Osteoporosis is usually considered as a post-menopause disease
prevalent in females. Consequently, its importance in males has
not been underscored enough in practice (Holloway, Kotowicz,
Lane, Brennan, & Pasco, 2015). Over the past few years, however,* Corresponding author. Tel.: +86 13588173827; fax: +86 057187312095.
E-mail addresses: bianpingda@hotmail.com (P. Bian), shousor@126.com
(Z. Shou).
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0167-4943/ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access 
nd/4.0/).epidemiological and observational studies have shown that
osteoporosis increasingly becomes an important heath challenge
in males (Park et al., 2011; Watts et al., 2012). Take hip fracture for
example, despite that the number of cases diagnosed in males only
account for about 30% of the total of both genders, the mortality
resulted from this condition in males is higher than that observed
in females (Arakaki et al., 2011; Chaysri et al., 2015). As a result,
identifying factors associated with osteoporosis in males helps to
reduce the burden of this disease through implementing early
prevention strategies.
BMD is clinically used as an indirect indicator of osteoporosis
and fracture risk. There are several methods to measure BMD.
Among them T-Score by dual energy X-ray absorptiometry (DXA) is
the gold-standard for osteoporosis diagnosis (Santos, Romeu,
Canhao, Fonseca, & Fernandes, 2010). Femoral neck, total hip, and
lumbar spine (L1–L4) are three most commonly-used diagnostic
sites by clinicians. Femoral neck has been considered as the most
reliable because the measurement of femoral neck bone mineral
density (FNBMD) is less inﬂuenced by degenerative changes and
the position of the leg than others (Kanis, Johansson, Oden, &
McCloskey, 2012). Thus far, there have been several investigationsarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
Table 1
Pre-existing diseases in 1177 very elderly Chinese males.
Pre-existing diseases Number Percentage
Hypertension 921 78.25
Coronary heart disease 180 15.29
Type 2 diabetes mellitus 316 26.85
COPD 372 31.61
Chronic gastritis 378 32.13
Abbreviation: COPD: chronic obstructive pulmonary disease.
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in males (Lopes, Ferreira, Coeli, & Farias, 2009; Sxholtissen et al.,
2009), but study on factors correlated with FNBMD in males aged
80 or more (very elderly males) has not been reported.
With an attempt to identify factors correlated with risk for
osteoporosis in very elderly males, we investigated 1177 very elderly
Chinese malesby performing FNBMD, biochemical parameters, bone
turnover markers, and serum sex steroids assays, and conducting
univariate and multivariate analyses. We found that age, body mass
index (BMI), concomitant chronic obstructive pulmonary disease
(COPD), serumb-C-telopeptide of type 1 collagen (b-CTX), parathy-
roid hormone (PTH), and estradiol are independent factors
correlated with the FNBMD in very elderly males.
2. Materials and methods
2.1. Study subjects
During this two-year study (from January 2013 to December
2014), 1177 Chinese very elderly males were recruited from the
Center for Diagnosis and Treatment of Osteoporosis, Zhejiang
Provincial People’s Hospital. The very elderly males with Paget’s
disease, rheumatoid arthritis, multiple myeloma, primary hyper-
parathyroidism, thyrotoxicosis, chronic renal failure, or those
receiving bone-active drugs (corticosteroids, bisphosphonates,
denosumab, raloxifene, teriparatide, etc.) were excluded from the
study. Written informed consents were obtained from all
participants, and the study got approval from the institutional
review board of Zhejiang Provincial People’s Hospital.
2.2. Demographic and anthropometric investigation
For all participants, demographic characteristics including
name and age were recorded, and data on pre-existing diseases
such as hypertension, coronary heart disease, type 2 diabetes
mellitus, COPD, and chronic gastritis were collected. All partic-
ipants underwent anthropometric measurement. Weight (kg) and
height (m) were measured barefoot and in lightweight indoor
clothing, and the BMI calculated as the result of weight divided by
height squared.
2.3. Measurement of FNBMD
The FNBMD was measured by DXA (GE Lunar Prodigy Scanner,
GE Lunar Corporation, WI, USA), and expressed in grams per square
centimeter. Though DXA was performed at femoral neck, total hip
and lumbar spine, only the FNBMD was used as an index for
analysis. The coefﬁcient of variation (CV) was 1.5% for FNBMD.
Quality control procedures were carried out and site cross-
calibration performed using the European Spine Phantom.
2.4. Bone turnover markers assay
In early morning, fasted venous blood samples were collected
from participants. Serum bone turnover markers were determined
using an automatic device (Roche Cobas e601 Automated Analyzer,
Roche Diagnostics, Tokyo, Japan) with standard methods. The
intra- and inter-assay CV were 2.0% and 4.2% for b-CTX, 0.8% and
4.0% for N-terminal propeptide of type 1 collagen (P1NP), 0.5% and
1.4% for osteocallin, 1.4% and 3.5% for 25-hydroxyvitamin D3,
and 1.1% and 2.0% for PTH, respectively.
2.5. Determination of biochemical parameters
Biochemical parameters were determined by using an
automatic analyzer (HITACHI 7600-010 Clinical Analyzer, RocheDiagnostics, Tokyo, Japan) with standard methods. The intra- and
inter-assay CV were 2.4% and 4.2% for serum uric acid, 2.0% and
3.1% for glucose, 2.5% and 4.0% for creatinine, 3.5% and 5.2% for
triglyceride, 2.0% and 3.7% for total cholesterol, 3.8% and 5.3% for
high-density lipoprotein cholesterol (HDL-C), 3.85% and 6.4% for
low-density lipoprotein cholesterol (LDL-C), 2.0% and 4.7% for high
sensitivity C-reactive protein (Hs-CRP), 1.5% and 2.9% for potassi-
um, 1.2% and 3.3% for sodium, 1.25% and 4.3% for chlorine, 2.0% and
5.5% for calcium, 2.7% and 4.2% for phosphate, 4.0% and 6.5% for
iron, and 4.3% and 7.0% for alkaline phosphatase, respectively.
2.6. Detection of sex steroids
Sex steroids were detected using an automatic device (ARCHI-
TECT Plus i2000SR, Abbott Diagnostics, IL, USA). Serum follicle-
stimulating hormone, luteinizing hormone, estradiol, prolactin,
progesterone, and testosterone were measured by enzyme
immunoﬂuorometry, and all had inter-and intra-assay CV less
than 8.33%.
2.7. Statistical analysis
Continuous variables were expressed as mean  standard
deviation (SD). The one-sample Kolmogorov–Smirnov test was
applied to assess data distribution. The means of quantitative
variables were compared by the independent sample t-test. Linear
correlations were determined using Spearman’s rank-order
correlation coefﬁcient, and stepwise multiple regression analysis
was performed to determine independent correlative factors of
FNBMD. All statistical tests were two-sided, and a p value
<0.05 was considered of statistical signiﬁcance. All statistical
analyses were performed with SPSS software version 17.0 (SPSS,
Inc Chicago, IL, USA).
3. Results
3.1. Clinical characteristics of subjects
The study included 1177 Chinese males with a mean age of
84.65  3.48 (range 80–96 years). The pre-existing diseases of all
participants were outlined in Table 1.
Other clinical characteristics including FNBMD, age, BMI and
results from bone turnover markers, biochemical parameters, and
sex steroids assays were summarized in Table 2.
3.2. Univariate correlation analyses of FNBMD with clinical
parameters in very elderly Chinese males
The univariate analyses demonstrated that FNBMD was
signiﬁcantly related to COPD, age, BMI, serum uric acid,
triglycerides, HDL-C, iron, alkaline phosphatase, b-CTX, P1NP,
osteocallin, PTH, follicle-stimulating hormone, and estradiol, as
shown in Table 3. In contrast, there was no correlation found
between FNBMD and other clinical parameters such as hyper-
tension, coronary heart disease and type 2 diabetes mellitus.
Table 2
Clinical characteristics of 1177 very elderly Chinese males.
Variables x  s
FNBMD(g/cm2) 0.82  0.14
Age (years) 84.65  3.48
BMI (kg/m2) 23.35  3.26
b-CTX (ng/ml) 0.34  0.19
P1NP(ng/ml) 39.08  18.44
Osteocalin (ng/ml) 17.79  6.98
25-hydroxyvitamin D3 (ng/ml) 12.81  10.23
PTH (pg/ml) 50.43  21.29
Uric acid (mmol/L) 369.84  86.73
Glucose (mmol/L) 5.66  1.09
Creatinine (mmol/L) 106.35  25.14
Triglycerides (mmol/L) 1.36  0.76
Total cholesterol (mmol/L) 4.68  0.98
HDL-C (mmol/L) 1.37  0.36
LDL-C (mmol/L) 2.73  0.87
Hs-CRP (mg/L) 4.92  1.47
Potassium (mmol/L) 4.06  0.36
Sodium (mmol/L) 140.61  2.65
Chlorine (mmol/L) 101.81  3.33
Calcium (mmol/L) 2.33  0.11
Phosphate (mmol/L) 1.06  0.16
Iron (mmol/L) 17.92  5.85
Alkaline phosphatase (U/L) 78.62  30.10
Follicle-stimulating hormone (IU/L) 23.83  18.18
Luteinizing hormone (IU/L) 10.87  7.41
Estradiol (pg/ml) 26.64  11.01
Prolactin (ng/ml) 19.45  13.18
Progesterone (ng/ml) 0.31  0.19
Testosterone (ng/ml) 4.61  2.54
Abbreviation: BMI: body mass index, HDL-C: high-density lipopro-
tein cholesterol, LDL-C: low-density lipoprotein cholesterol, Hs-
CRP: high sensitivity C-reactive protein, b-CTX: b-C-telopeptide of
type 1 collagen, P1NP: N-terminal propeptide of type 1 collagen,
PTH: parathyroid hormone.
Table 3
Univariate correlation analyses of FNBMD with selected clinical parameters in
1177 very elderly Chinese males.













Follicle-stimulating hormone 0.102 0.007
Estradiol 0.134 0.003
Abbreviation: COPD: chronic obstructive pulmonary disease, BMI: body mass index,
HDL-C: high-density lipoprotein cholesterol, b-CTX: b-C-telopeptide of type
1 collagen, P1NP: N-terminal propeptide of type 1 collagen, PTH: parathyroid
hormone.
a FNBMD of very elderly males with COPD: 0.79  0.13 g/cm2; FNBMD of those
without COPD: 0.83  0.13 g/cm2.
Table 4
Multivariate correlation analysis of clinical parameters associated with FNBMD in
1177 very elderly Chinese males.
Variables b t P 95%CI
BMI 0.009 6.117 0.001 0.006 to 0.012
b-CTX 0.097 3.727 0.001 0.149 to 0.046
COPD 0.027 2.633 0.009 0.047 to 0.007
PTH 0.001 2.882 0.004 0.001 to 0.000
Age 0.003 2.109 0.035 0.006 to 0.000
Estradiol 0.001 2.075 0.038 0.000 to 0.002
Abbreviation: BMI: body mass index, b-CTX: b-C-telopeptide of type 1 collagen,
COPD: chronic obstructive pulmonary disease, PTH: parathyroid hormone.
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parameters in very elderly Chinese males
Multivariate regression analysis (with FNBMD as the dependent
variable) revealed that BMI (b = 0.009, P < 0.001), b-CTX
(b = 0.097, P < 0.001), COPD (b = 0.027, P = 0.009), PTH
(b = 0.001, P = 0.004), age (b = 0.003, P = 0.035), and estradiol
(b = 0.001, P = 0.038) were independent correlative factors with
FNBMD in the very elderly Chinese males, as shown in Table 4.4. Discussion
Low BMD is a major risk factor for fractures. BMD is a dynamic
parameter, and declines with the advance of age, especially in the
late decades of life (Nguyen, Center, Eisman, & Nguyen, 2007). Bone
loss occurs with ageing in males as same as in females (Gouveia
et al., 2014). Longitudinal studies suggested that this loss might
reach 5–10% of total bone mass/decade (Anderson, Roggenkamp, &
Suchindran, 2012). As expected, the current study showed that age
is negatively correlated with FNBMD in very elderly males. Among
reasons for it, such as deﬁciency of nutrition, lack of exercise, and
some chronic diseases, the main one is that elderly males
experience gradual decline in serum steroids as they age (Woo
et al., 2012). Though both androgen and estrogens are important
for the maintenance of bone mass in adulthood for males,
evidences from cross-sectional and longitudinal studies suggested
that serum estradiol level was highly related to BMD, bone
turnover and bone loss compared with testosterone in elderly
males (Cauley et al., 2010; Yoshimura et al., 2011).
Similar to these fore-mentioned observations, our current study
showed that low serum estradiol was independently correlated
with low FNBMD, suggesting estrogens play a critical role in BMD
for very elderly males. An essential role for estrogens in bone
maturation was illustrated by the ﬁndings that osteopenia and
failure of epiphyseal growth plate fusion occurred in an estrogen
receptor a-negative males and in male patients with complete
aromatase deﬁciency (Rochira et al., 2010; Vandenput & Ohlsson,
2010). After association with corresponding receptors, estrogens
curb the function of osteoclasts, promote the combining of 25-
hydroxyvitamin D3, halter bone absorption by PTH (Lapauw et al.,
2009; Wang & Stern, 2011). Therefore, taking selective estrogen
receptor modulators (SERMs) to reduce bone loss is important to
increase FNBMD in very elderly males (Nath & Sitruk-Ware, 2009).
In accordance with study by Dogan A and colleagues (Dogan,
Nakipoglu-Yüzer, Yıldızgören, & Ozgirgin, 2010), where a positive
correlation was determined between the FNBMD measurements
and the BMI in males, we found that BMI was one of the
independent factors positively correlated to FNBMD. As a result, to
keep a moderately high BMI represents a possible way to increase
FNBMD in very elderly males. There are two possible reasons why
higher BMI leads to a higher BMD. One is that high BMI can
increase the heavy burden of femoral neck, thus stimulating
osteoblasts of femoral neck to promote bone remodeling (Lopes
et al., 2009). The another is that the nutrition conditions of very
elderly males with higher BMI is usually better than those with
lower BMI, which is beneﬁcial to bone metabolism (Inderjeeth,
Chan, Kwan, & Lai, 2012). In order to maintain an optimal BMI, the
very elderly males are advised to have a balanced diet, take
moderate amount of exercise, keep regular hours, and so on.
The present study demonstrated that serum b-CTX was an
independent factors negatively associated with FNBMD in the very
elderly Chinese males, informing us to decrease the level of serum
b-CTX is a possible way to increase FNBMD. b-CTX, a segment of
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recommended as bone resorption marker and is useful for
monitoring osteoporosis treatment (Nishizawa et al., 2012).
Bisphosphonates, such as alendronate, risedronate, and zoledronic
acid, which are most frequently-used anti-osteoporosis medica-
tions, can impact the functions of osteoclasts. Following treatment
with bisphosphonates, a decrease in b-CTX and an increase in BMD
were observed (Inderjeeth et al., 2012; Romme et al., 2012).
It was also showed in the study that concomitant COPD was
related to low FNBMD in the very elderly Chinese males. Prevention
and cure of COPD may contribute to increasing the FNBMD. COPD, a
primary disease of the lung, is associated with extrapulmonary
effects such as muscle weakness and osteoporosis (Rittayamai,
Chuaychoo, & Sriwijitkamol, 2012; Sarkar, Bhardwaj, Madabhavi, &
Khatana, 2015). The cause of bone loss in elder patients with COPD
might be due to multiple factors, including corticosteroid therapy,
smoking, physical deconditioning, vitamin D deﬁciency, hypogo-
nadism, and chronic systemic inﬂammation. For this reason, we
should pay more attention to this chronic condition in very elderly
males through smoking cessation, nutritional support, rational use
of inhaled bronchodilators, oral theophylline and phosphodiester-
ase-4 inhibitor (Vijayan, 2013).
Finally, Our study indicated that serum PTH was an independent
factor negatively correlated FNBMD. To decrease the serum level of
PTH is a potential intervention to increase FNBMD. PTH is an
important hormone in bone metabolic regulation and has double
functions to promote bone synthesis and bone absorption (Nagasaka
et al., 2011). Some epidemiological and observational studies have
shown that the serum PTH increases with age in elder males. There
are some facts to explain for it, for example, increase of age,
deﬁciencyofvitaminD, lack ofestrogen(Kulak etal.,2012; Tajaretal.,
2013), and so on. Sufﬁcient vitamin D supply is one of the useful ways
to reduce PTH in elderly males (Okazaki et al., 2011).
The limitations of this study should be addressed. First, the
nature of cross-sectional study makes it difﬁcult to fully explore
the time course of bone loss. Second, some other risk factors of
osteoporosis, for example, lack of milk, high salt intake, alcohol or
coffee intake, smoking habits, previous fracture, family history of
osteoporosis and/or fracture (Kanis et al., 2012; Rodrigues et al.,
2012) were not took into consideration in the study. Further
longitudinal studies are warranted to explore the inﬂuential effects
of these factors.
In conclusion, the FNBMD in the very elderly Chinese males are
associated with BMI, concomitant COPD, serum levels of b-CTX,
PTH, and estradiol. An integrated intervention should be imple-
mented to increase the BMD of the very elderly males, with special
attention to preventing and curing COPD, reducing serum b-CTX
and PTH, as well as keeping a proper BMI and serum estradiol level.
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